NCT00056758View on ClinicalTrials.gov

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2003

Conditions
HIV Infections
Interventions
BIOLOGICAL

Autologous Dendritic Cell HIV Vaccination

Trial Locations (1)

15213

University of Pittsburgh, Pitt Treatment Evaluation Unit, Pittsburgh

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00056758 - HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs | Biotech Hunter | Biotech Hunter